Medicine
Zurnai 1.5 mg/0.5 mL injection
Zurnai 1.5 mg/0.5 mL injection is a prescription medicine containing Nalmefene for intramuscular, subcutaneous use, marketed by Knoa Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT FREEZE OR REFRIGERATE. Store at controlled room temperature 20°C to…
Key facts
- Active ingredient (INN)
- Nalmefene
- Brand
- Zurnai
- Strength
- 1.5 mg/0.5 mL
- Dosage form
- Injection
- Route
- Intramuscular, subcutaneous
- Packs
- 1 syringe of 0.5 mL
- Marketing authorisation holder
- Knoa Pharma
- Manufacturer
- Knoa Pharma
- Origin register
- US FDA, United States
- Storage
- DO NOT FREEZE OR REFRIGERATE. Store at controlled room temperature 20°C to 25°C (68°F to 77°F), with excursions permitted between 5°C to 40°C (41°F to 104°F). During storage, check ZURNAI through the viewing window of the auto-injector every 30 days. Store in a clean dry place. Protect from light. Store ZURNAI securely and dispose of properly in a sharps container.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07BB05 Nalmefene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 August 2025
- Identifiers
- RxCUI 2720806, 2720812DailyMed set ID a59a5847-9fe4-4341-a203-be0a5e6d3e36NDC 59011-962Application NDA218590
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / .5 mL in 1 syringe, glass | 59011-962-01 | Knoa Pharma | 7 August 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nalmefene
Clinical summary
Nalmefene is an opioid antagonist indicated for the emergency treatment of known or suspected overdose induced by natural or synthetic opioids in adults and pediatric patients aged 12 years and older, among other approved uses. MedsAcross supplies Nalmefene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NalmefeneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OPVEE prescribing information (Indivior) · U.S. National Library of Medicine, DailyMed
- Selincro: European public assessment report (EPAR) · European Medicines Agency
Need Zurnai 1.5 mg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.